Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab

Table 5

(a) Descriptive statistics and correlations between main variables at baseline ()

	(SD)	FSS^1	Anx^2	Dep^3	CFQ^4	Glob^5	CF^6	EF^7	PF^8	RF^9	SF^10	FA^11
FSS^1	3.0 (1.8)		0.71	0.49	0.76	-0.41	-0.18	-0.66	-0.25	-0.26	-0.34	0.75
Anx^2	5.8 (6.0)			0.30	0.78	-0.48^m	-0.23	-0.84	-0.29	-0.26	-0.51	0.67
Dep^3	5.5 (3.4)				0.24	-0.24	-0.31	-0.37	-0.28	-54	-0.09	0.42
CFQ^4	39.8 (23.1)					-0.43^m	-0.51	-73	-0.24	-0.10	-0.34	0.78

(b) Descriptive statistics and correlations between main variables at one-year follow-up ()

	(SD)	FSS^1	Anx^2	Dep^3	CFQ^4	Glob^5	CF^6	EF^7	PF^8	RF^9	SF^10	FA^11
FSS^1	2.9 (1.5)		0.60	0.46^m	0.73	-0.04	-0.52	-0.49^m	0.04	-0.31	-0.29	0.32
Anx^2	6.1 (6.1)			0.81	0.73	-0.32	-0.83	-0.86	0.10	-0.46^m	-0.56	0.27
Dep^3	4.9 (4.6)				0.66	-0.68	-0.91	-0.77	-0.37	-0.73	-0.65	0.3
CFQ^4	40.5 (22.2)					-0.16	-74	-0.71	0.10	-0.33	-0.39	0.27

Note: m = marginally significant. ; . diagonal = variances. ¹Fatigue Severity Scale; ²HADS Anxiety; ³HADS Depression; ⁴Cognitive Failure Questionnaire; ⁵global HRQoL EORTC QLQ-C30; ⁶Cognitive Function EORTC QLQ-C30; ⁷Emotional Function EORTC QLQ-C30; ⁸Physical Function EORTC QLQ-C30; ⁹Role Function EORTC QLQ-C30; ¹⁰Social Function EORTC QLQ-C30; ¹¹Symptom Scale EORTC QLQ-C30.